KDOQI (Kidney Disease Outcomes Quality Initiative)


NKF KDOQI GUIDELINES

Executive Summaries | Anemia | Hemodialysis | Peritoneal Dialysis |
Vascular Access | Nutrition | CKD 2002 | Dyslipidemias | Bone Metabolism | Hypertension and Antihypertensive Agents | Cardiovascular Disease in Dialysis Patients | History of K/DOQ | Pediatric Bone |

KDOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Children With Chronic Kidney Disease


Work Group Membership

Workgroup Co-Chairs

Craig B. Langman, MD
Northwestern University Feinberg School of Medicine
Children's Memorial Hospital
Chicago, IL

Isidro B. Salusky, MD
David Geffen School of Medicine at UCLA
Los Angeles, CA

 

Work Group

Larry Greenbaum, MD, PhD
Medical College of Wisconsin
Milwaukee, WI
Pauline Nelson, RD
UCLA Medical Center
Los Angeles, CA

Harald Jueppner, MD
Massachusetts General Hospital
Harvard Medical School
Boston, MA

Anthony Portale, MD
University of California San Francisco
San Francisco, CA
Mary Leonard, MD
Children's Hospital of Philadelphia
Philadelphia, PA
Bradley A. Warady, MD
The Children's Mercy Hospital
Kansas City, MO

Consultants to the Work Group

Richard E. Bowen, MD
Assistant Clinical Professor
David Geffen School of Medicine at UCLA
Los Angeles, CA

William L. Oppenheim, MD
David Geffen School of Medicine at UCLA
Los Angeles, CA